Detail akcie EDAP TMS SA Depository Receipt online

Business Summary: Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Edap Tms SA (ADR) revenues increased 10% to EUR60.4M. Net loss applicable to common stockholders increased from EUR2.9M to EUR21.2M. Revenues reflect High Intensity Focused Ultrasound Division segment increase of 32% to EUR20.6M, Distribution Division segment increase of 7% to EUR29.9M. Higher net loss reflects High Intensity Focused Ultrasound Division segment loss increase from EUR4.9M to EUR14.8M.